71
Participants
Start Date
June 30, 2005
Primary Completion Date
June 30, 2008
Study Completion Date
December 31, 2010
Lunesta
"Both groups receive eszopiclone. Group 1 receives Lunesta (eszopiclone) in intervention weeks 1 and 2 followed by placebo in weeks 3 and 4.~Group 2 receives placebo in intervention weeks one and two followed by Lunesta (eszopiclone) in weeks 3 and 4."
Sumitomo Pharma America, Inc.
INDUSTRY
Emory University
OTHER